dapa ckd
Published 3 years ago • 395 plays • Length 7:38Download video MP4
Download video MP3
Similar videos
-
6:11
dapa-ckd: does confirmed renoprotection make the case for first-line sglt2 inhibition? | luigi gnudi
-
9:06
sglt2 inhibitors in chronic kidney disease
-
58:38
nephrology grand rounds: sglt2 inhibitors
-
2:53
dapa ckd trial
-
8:14
dapa-ckd: renal benefits of sglt2 inhibition in people with and without diabetes | hiddo heerspink
-
9:32
dapa ckd - trial
-
2:03
dapagliflozin clinically and cost effective in patients with chronic kidney disease dapa ckd trial
-
14:44
dapa-ckd by amr el-husseini
-
3:21
esc tv at esc congress 2020 - dapa-ckd (investigator)
-
1:05:08
new glucose-lowering drugs and kidney protection in ckd
-
49:14
sglt2 inhibitors: can these drugs slow the progression of chronic kidney disease?
-
2:17
esc tv at esc congress 2020 - dapa-ckd (discussant)
-
2:12
dapa-ckd discussion - manesh patel, md
-
0:29
could you have kidney disease? know the signs!
-
1:52
empa-kidney results: empagliflozin reduces kidney disease progression and cardiovascular deaths
-
4:17
esc 2020: commentary on the dapa-ckd study — dr giuseppe galati
-
24:32
kdigo diabetes management in ckd guideline
-
19:30
dapagliflozin - a nephrologist perspective by dr ratan jha